Donation crowdfunding is a kind of cr owdfunding that has been popular in Korea for the last decade. This paper is an exploratory study to know what factors affect the result of crowdfundi ng, especially donation crowdfundin g. We use cross-sectional data and panel data of crowdfunding projects listed on HappyBean, which is the m ost popular donation crowdfunding pl atform in Korea. We tried to find the factors that have a positive impact on fundraising. One of the most importa nt factors is other participants' action s. This implies that peer effect or her ding effect exists in crowdfunding pla tform. The results of this study may be used to vitalize online donation fu ndraising through the strategic progr ess of the project proponent.

Background/Aims: Kidney transplantation (KT) is the best treatment for end-stage renal disease patients. Although previous studies have demonstrated that the clinical outcome following living related (LR) KT is better than that following unrelated (LUR) KT in ABO-compatible KT recipients, recent studies showed no differences in clinical outcomes between the two treatments. In this study, we compared the clinical outcomes of LR and LUR KT in ABO-incompatible KT recipients. Methods: From January 2011 to August 2013, 19 cases of ABO-incompatible KT were analyzed retrospectively. Eight kidneys (7 cases of parent-offspring and 1 case of siblings, Group 1) were donated from living-related donors and 11 (all spousal donors, Group 2) from living-unrelated donors. We investigated patient survival, graft survival, acute rejection, graft function, and complications. Results: On Kaplan-Meier analysis, patient and graft survival during follow-up were 87.5% and 87.5% in Group 1; both were 100% in Group 2. Acute rejection, graft function, and medical and surgical complications were not significantly different between the two groups. Conclusions: The short-term clinical outcomes between LR and LUR KT in ABO-incompatible KT recipients were equivalent. Most domestic cases of LUR KT are from spousal donors and the spousal donor will be a major donor in ABO-incompatible KT patients.

No abstract

No abstract